273 related articles for article (PubMed ID: 19172538)
1. Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction.
Blümel JE; Del Pino M; Aprikian D; Vallejo S; Sarrá S; Castelo-Branco C
Gynecol Endocrinol; 2008 Dec; 24(12):691-5. PubMed ID: 19172538
[TBL] [Abstract][Full Text] [Related]
2. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
[TBL] [Abstract][Full Text] [Related]
3. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women.
Warnock JK; Swanson SG; Borel RW; Zipfel LM; Brennan JJ;
Menopause; 2005; 12(4):374-84. PubMed ID: 16037752
[TBL] [Abstract][Full Text] [Related]
4. Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice.
Nappi RE; Albani F; Vaccaro P; Gardella B; Salonia A; Chiovato L; Spinillo A; Polatti F
Gynecol Endocrinol; 2008 Apr; 24(4):214-9. PubMed ID: 18382908
[TBL] [Abstract][Full Text] [Related]
5. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
de Paula FJ; Soares JM; Haidar MA; de Lima GR; Baracat EC
Maturitas; 2007 Jan; 56(1):69-77. PubMed ID: 16822626
[TBL] [Abstract][Full Text] [Related]
6. A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.
Gast MJ; Freedman MA; Vieweg AJ; De Melo NR; Girão MJ; Zinaman MJ;
Menopause; 2009; 16(2):247-56. PubMed ID: 19034054
[TBL] [Abstract][Full Text] [Related]
7. Sexual dysfunction in women with hyperprolactinemia: a pilot study report.
Kadioglu P; Yalin AS; Tiryakioglu O; Gazioglu N; Oral G; Sanli O; Onem K; Kadioglu A
J Urol; 2005 Nov; 174(5):1921-5. PubMed ID: 16217346
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
[TBL] [Abstract][Full Text] [Related]
9. Assessment of sexuality among middle-aged women using the Female Sexual Function Index.
Chedraui P; Perez-Lopez FR; San Miguel G; Avila C
Climacteric; 2009 Jun; 12(3):213-21. PubMed ID: 19117186
[TBL] [Abstract][Full Text] [Related]
10. [Sexual function in postmenopausal women using hormone replacement therapy].
Blumel JE; Bravo F; Recavarren M; Sarrá S
Rev Med Chil; 2003 Nov; 131(11):1251-5. PubMed ID: 14743685
[TBL] [Abstract][Full Text] [Related]
11. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
Kwee SH; Tan HH; Marsman A; Wauters C
Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
[TBL] [Abstract][Full Text] [Related]
12. Sexual functioning in postmenopausal women not taking hormone therapy in the Gynecological and Menopause Clinic, Songklanagarind Hospital measured by Female Sexual Function Index questionnaire.
Peeyananjarassri K; Liabsuetrakul T; Soonthornpun K; Choobun T; Manopsilp P
J Med Assoc Thai; 2008 May; 91(5):625-32. PubMed ID: 18672623
[TBL] [Abstract][Full Text] [Related]
13. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
14. Influence of weight reduction by sibutramine on female sexual function.
Kim KK; Kang HC; Kim SS; Youn BB
Int J Obes (Lond); 2006 May; 30(5):758-63. PubMed ID: 16404407
[TBL] [Abstract][Full Text] [Related]
15. The validity of the Menopause Specific Quality of Life Questionnaire in older women.
Kulasingam S; Moineddin R; Lewis JE; Tierney MC
Maturitas; 2008; 60(3-4):239-43. PubMed ID: 18760553
[TBL] [Abstract][Full Text] [Related]
16. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
El-Hage G; Eden JA; Manga RZ
Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
[TBL] [Abstract][Full Text] [Related]
18. The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status.
Ito TY; Polan ML; Whipple B; Trant AS
J Sex Marital Ther; 2006; 32(5):369-78. PubMed ID: 16959660
[TBL] [Abstract][Full Text] [Related]
19. Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women.
Utian W; Yu H; Bobula J; Mirkin S; Olivier S; Pickar JH
Maturitas; 2009 Aug; 63(4):329-35. PubMed ID: 19647382
[TBL] [Abstract][Full Text] [Related]
20. Sexual function in women with coronary artery disease: a preliminary study.
Kaya C; Yilmaz G; Nurkalem Z; Ilktac A; Karaman MI
Int J Impot Res; 2007; 19(3):326-9. PubMed ID: 17170712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
